tm
Seeing Is Believing
tm
Seeing Is Believing
APLS is currently covered by 17 analysts with an average price target of $35.33. This is a potential upside of $12.86 (57.23%) from yesterday's end of day stock price of $22.47.
Apellis Pharmaceuticals's activity chart (see below) currently has 457 price targets and 327 ratings on display. The stock rating distribution of APLS is 55.81% BUY, 41.86% HOLD and 2.33% SELL.
Analysts average stock forecasts to be materialized ratio is 65.41% with an average time for these price targets to be met of 233.54 days.
Highest price target for APLS is $48, Lowest price target is $18, average price target is $30.75.
Most recent stock forecast was given by ELIANA MERLE from BARCLAYS on 28-Jan-2026. First documented stock forecast 04-Dec-2017.
Currently out of the existing stock ratings of APLS, 24 are a BUY (55.81%), 18 are a HOLD (41.86%), 1 are a SELL (2.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Jan-2026
$24
$1.72 (7.72%)
$44
27 days ago
(28-Jan-2026)
5/11 (45.45%)
$0.93 (4.03%)
391
Buy Since 21-Jan-2026
$28
$5.72 (25.67%)
$24
1 months 3 days ago
(21-Jan-2026)
5/11 (45.45%)
$7.05 (33.65%)
29
Buy Since 15-Oct-2025
$26
$3.72 (16.70%)
$32
1 months 4 days ago
(20-Jan-2026)
10/15 (66.67%)
$5.53 (27.02%)
114
Buy Since 31-Mar-2020
$35
$12.72 (57.09%)
$39
1 months 11 days ago
(13-Jan-2026)
2/19 (10.53%)
$13.67 (64.09%)
570
Buy Since 19-Nov-2020
$28
$5.72 (25.67%)
$29
1 months 11 days ago
(13-Jan-2026)
11/21 (52.38%)
$6.67 (31.27%)
225
What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?
